Furthermore, in vitro experiments confirmed that the downregulation of CHREBP promoted the growth of GC cells and that the overexpression of CHREBP exerted inhibitory effects, which could be further proven by an in vivo tumor xenograft assay. This evidence concerns the gene MLXIPL and gastric cancer.